Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome

  • Barcelo Bennasar, Antonia|||0000-0002-3170-5439
  • Bauça, Josep Miquel|||0000-0001-8808-6870
  • Yáñez, Aina M.|||0000-0001-8527-3937
  • Fueyo, Laura
  • Gomez, Cristina
  • De la Peña, Mónica|||0000-0003-3276-776X
  • Pierola, Javier|||0000-0003-0759-5580
  • Rodriguez, Alberto
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Mediano, Olga|||0000-0001-7824-1523
  • Amilibia, Jose
  • Masdeu, María José|||0000-0003-0437-2074
  • Teran, Joaquin|||0000-0002-1680-4690
  • Montserrat Canal, José Ma|||0000-0003-3098-4605
  • Mayos, Merce|||0000-0003-3972-3671
  • Sánchez de la Torre, Alicia|||0000-0003-3446-1481
  • Barbé, Ferran|||0000-0002-2340-8928
BACKGROUND: Placental growth factor (PlGF) induces angiogenesis and promotes tissue repair, and plasma PlGF levels change markedly during acute myocardial infarction (AMI). Currently, the impact of obstructive sleep apnea (OSA) in patients with AMI is a subject of debate. Our objective was to evaluate the relationships between PlGF levels and both the severity of acute coronary syndrome (ACS) and short-term outcomes after ACS in patients with and without OSA. METHODS: A total of 538 consecutive patients (312 OSA patients and 226 controls) admitted for ACS were included in this study. All patients underwent polygraphy in the first 72 hours after hospital admission. The severity of disease and short-term prognoses were evaluated during the hospitalization period. Plasma PlGF levels were measured using an electrochemiluminescence immunoassay. RESULTS: Patients with OSA were significantly older and more frequently hypertensive and had higher BMIs than those without OSA. After adjusting for age, smoking status, BMI and hypertension, PlGF levels were significantly elevated in patients with OSA compared with patients without OSA (19.9 pg/mL, interquartile range: 16.6-24.5 pg/mL; 18.5 pg/mL, interquartile range: 14.7-22.7 pg/mL; p<0.001), and a higher apnea-hypopnea index (AHI) was associated with higher PlGF concentrations (p<0.003). Patients with higher levels of PlGF had also an increased odds ratio for the presence of 3 or more diseased vessels and for a Killip score.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea, a post hoc study of the ISAACC trial

  • Pinilla, Lucía|||0000-0003-2825-4056
  • Esmaeili, Neda
  • Labarca, Gonzalo|||0000-0002-0069-3420
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Torres, Gerard|||0000-0002-1417-7320
  • Gracia-Lavedan, Esther
  • Mínguez, Olga
  • Martínez López, Dolores
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Masdeu, Maria José
  • Mediano, Olga|||0000-0001-7824-1523
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Cabriada-Nuño, Valentín|||0000-0003-1124-7108
  • Duran-Cantolla, Joaquin|||0000-0001-8172-9415
  • Mayos, Merce|||0000-0003-3972-3671
  • Coloma Navarro, Ramón|||0000-0002-4280-415X
  • Montserrat, Josep María
  • De la Peña, Mónica|||0000-0003-3276-776X
  • Hu, Wen-Hsin
  • Messineo, Ludovico
  • Sehhati, Mohammadreza
  • Wellman, Andrew
  • Redline, Susan
  • Sands, Scott
  • Barbé, Ferran|||0000-0002-2340-8928
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Azarbarzin, Ali|||0000-0002-4986-4753
Hypoxic burden (HB) has emerged as a strong predictor of cardiovascular risk in obstructive sleep apnoea (OSA). We aimed to assess the potential of HB to predict the cardiovascular benefit of treating OSA with continuous positive airway pressure (CPAP). This was a post hoc analysis of the ISAACC trial (: NCT01335087) including non-sleepy patients with acute coronary syndrome (ACS) diagnosed with OSA (apnoea-hypopnoea index ≥15 events·h -1) by respiratory polygraphy. Patients were randomised to CPAP or usual care and followed for a minimum of 1 year. HB was calculated as the total area under all automatically identified desaturations divided by total sleep time. Patients were categorised as having high or low baseline HB according to the median value (73.1%min·h -1). Multivariable Cox regression models were used to assess whether the effect of CPAP on the incidence of cardiovascular outcomes was dependent on the baseline HB level. The population (362 patients assigned to CPAP and 365 patients assigned to usual care) was middle-aged (mean age 59.7 years), overweight/obese and mostly male (84.5%). A significant interaction was found between the treatment arm and the HB categories. In the high HB group, CPAP treatment was associated with a significant reduction in the incidence of cardiovascular events (HR 0.57, 95% CI 0.34-0.96). In the low HB group, CPAP-treated patients exhibited a trend toward a higher risk of cardiovascular outcomes than those receiving usual care (HR 1.33, 95% CI 0.79-2.25). The differential effect of the treatment depending on the baseline HB level followed a dose-response relationship. In non-sleepy ACS patients with OSA, high HB levels were associated with a long-term protective effect of CPAP on cardiovascular prognosis.